Arteriovenous malformations are potentially serious vascular anomalies that are rarely encountered in the eyelid and require a multidisciplinary approach.
We would like to describe the technical and clinical aspects related to the treatment of palpebral arteriovenous malformation with selective embolization, followed by surgical resection.
A 40-year-old patient presented with an isolated high-flow palpebral arteriovenous malformation. Transarterial embolization, using a liquid embolic agent (PHIL™), was performed in this patient.
Angiographic and clinical follow-up revealed good results with clinical regression of the mass.
Although endovascular treatment of palpebral arteriovenous malformations is technically challenging, good functional and cosmetic result was achieved. Arteriovenous malformation embolization using PHIL™ seems to be very effective and makes subsequent surgical procedure safe and feasible.
Evidence obtained from multiple time series with or without the intervention, such as case studies. Dramatic results in uncontrolled trials might also be regarded as this type of evidence
Robert Juszkat, Bartosz ?abicki, Katarzyna Stanistawska, Karolina Szepelak, Bartosz K?dzio?ka, Piotr Sosnowski, Jaros?aw Koci?cki
- Rootman, J, Heran, MK, Graeb, DA. Vascular malformations of the orbit: Classification and the role of imaging in diagnosis and treatment strategies. Ophthal Plast Reconstr Surg 2014; 30: 91–104. Google Scholar, Crossref, Medline
- Shaver, J. Eyelid arteriovenous malformation treated with embolization leading to a branch retinal artery occlusion. Optometry 2011; 82: 744–750. Google Scholar, Crossref, Medline
- Juszkat, R, ?abicki, B, Ch?ci?ski, P Endovascular treatment of arteriovenous malformations. Aesth Plast Surg 2009; 33: 639–642. Google Scholar, Crossref, Medline
- Barr, JC, Ogilvy, CS. Selection of treatment modalities or observation of arteriovenous malformations. Neurosurg Clin N Am 2012; 23: 63–75. Google Scholar, Crossref, Medline
- Koçer, N, Han?mo?lu, H, Batur, ? Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations. Diagn Interv Radiol 2016; 22: 184–189. Google Scholar, Crossref, Medline
- In’t Veld, M, Willems, PW. Absence of skin discoloration after transarterial embolization of a subcutaneous auricular arteriovenous malformation with PHIL. Interv Neuroradiol 2016; 22: 606–610. Google Scholar, Link
- Choudhri, O, Ivan, MI, Lawton, MT. Transvenous approach to intracranial arteriovenous malformations: Challenging the axioms of arteriovenous malformation therapy. Neurosurgery 2015; 77: 644–651. Google Scholar, Crossref, Medline
- Leyon, JJ, Chavda, S, Thomas, A Preliminary experience with the liquid embolic material agent PHIL (Precipitating Hydrophobic Injectable Liquid) in treating cranial and spinal dural arteriovenous fistulas: Technical note. J Neurointerv Surg 2016; 8: 596–602. Google Scholar, Crossref, Medline
- Samaniego, EA, Kalousek, V, Abdo, G Preliminary experience with Precipitating Hydrophobic Injectable Liquid (PHIL) in treating cerebral AVMs. J Neurointerv Surg 2016; 8: 1253–1255. Google Scholar, Crossref